Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes

Archives of Internal Medicine

Volumn 162, Issue 22, 2002, Pages 2589-2593

  Ageno, Walter ^a   Finazzi, Sergio ^a   Steidl, Luigi ^a   Biotti, Maria Grazia ^a   Mera, Valentina ^a   D'Eril, GianVico Melzi ^a   Venco, Achille ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; D DIMER; FIBRINOLYTIC AGENT; WARFARIN;

AGED; ARTICLE; ASSAY; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EMBOLISM; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PLASMA; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 0037049352     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.22.2589     Document Type: Article

References (20)

1. Mohr JP, Sacco RL. Classifications of ischemic strokes. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke Pathophysiology, Diagnosis and Management. New York, NY: Churchill Livingston Inc; 1992:271-283.
2. Madden KP, Karanjia PN, Adams H Jr, Clark WR. Accuracy of the initial stroke subtype diagnosis in the TOAST study: Trial of ORG 10172 in Acute Stroke Treatment. Neurology. 1995;45:1975-1979.
3. Feinberg WM, Bruck DC, Ring ME, Corrigan JJ Jr. Hemostatic markers in acute stroke. Stroke. 1989;20:592-597.
4. Fisher M, Francis R. Altered coagulation in cerebral ischemia: Platelet, thrombin, and plasmin activity. Arch Neurol. 1990;47:1075-1079.
5. Fon EA, Mackey A, Coté R, et al. Hemostatic markers in acute transient ischemic attacks. Stroke. 1994;25:282-286.
6. Takano K, Yamaguchi T, Uchida K. Markers of a hypercoagulable state following acute ischemic stroke. Stroke. 1992;23:194-198.
7. de Moerloose. D-dimer assays for the exclusion of venous thromboembolism: Which test for which diagnostic strategy? Thromb Haemost. 2000;83:180-181.
8. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview. Thromb Haemost. 1994;71:1-6.
9. WHO MONICA Project Principal Investigators. The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. J Clin Epidemiol. 1988;41:105-114.
10. Johnson CJ, Kittner SJ, McCarter RJ, et al. Interrater reliability of an etiologic classification of ischemic stroke. Stroke. 1995;26:46-51.
11. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
12. Edwards DR, Chen YW, Diringer MN. Unified Neurological Stroke Scale is valid in ischemic and hemorrhagic stroke. Stroke. 1995;26:1852-1858.
13. van der Graaf F, van den Borne H, van der Kolk M, de Wild PJ, Janssen GW, van Uum SH. Exclusion of deep venous thrombosis with D-dimer testing: Comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost. 2000;83:191-198.
14. Boneu B, Aptel I, Nguyen F, et al. Liatest D-D, a new fast assay to determine D-dimers, has performances comparable to classical ELISA for diagnosis of deep vein thrombosis [abstract]. Thromb Haemost. 1997;77(suppl):159. Abstract PD-651.
15. Boudaoud L, Roussi J, Vallee C, et al. Evaluation of Sta-Liatest D-D in exclusion of venous thromboembolism in paraplegic patients: Comparison with 5 other D-dimer assays [abstract]. Thromb Haemost. 1997;77(suppl):42-43. Abstract PS-169.
16. Breton E, Le Querrec A, Lechavalier B, et al. Comparative study of four new and rapid D-dimer assays to exclude deep vein thrombosis or pulmonary embolism [abstract]. Thromb Haemost. 1997;77(suppl):42. Abstract PS-168.
17. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol. 1990;16:377-380.
18. Lip GYH, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin therapy. Br Heart J. 1995;73:527-533.
19. Lip GYH, Lip PL, Zarifis J, et al. Fibrin D-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation: Effects of introducing ultra-low-dose warfarin and aspirin. Circulation. 1996;94:425-431.
20. Lowe GDO, Rumley A. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events. Thromb Haemost. 1999;82:667-672.